Treatment of Adolescent Suicide Attempters (TASA)

Sponsor
New York State Psychiatric Institute (Other)
Overall Status
Completed
CT.gov ID
NCT00080158
Collaborator
National Institute of Mental Health (NIMH) (NIH)
120
6
39
20
0.5

Study Details

Study Description

Brief Summary

The purpose of this study is to compare the effects of three types of treatments for depressed teenagers who have attempted suicide.

Condition or Disease Intervention/Treatment Phase
Phase 2/Phase 3

Detailed Description

Suicide is the third leading cause of death in adolescents and is a major public health problem. Depression is the most common diagnosis for adolescent suicide attempts. Little is known about what treatment is best for these adolescents since they are usually excluded from participation in research studies.

Participants in this study will be randomly assigned to receive carefully monitored antidepressant medication with routine support and management, cognitive behavioral therapy (CBT), or a combination of antidepressant medication plus CBT.

Study Design

Study Type:
Interventional
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Study Start Date :
Mar 1, 2004
Actual Study Completion Date :
Jun 1, 2007

Outcome Measures

Primary Outcome Measures

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    12 Years to 18 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • At least one suicide attempt or interrupted attempt within the past 45 days

    • Continuously reside with a primary caretaker (parent, legal guardian, foster parent) for at least 6 months that can provide legal consent

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Johns Hopkins University Baltimore Maryland United States 21287
    2 New York University Child Study Center New York New York United States 10016
    3 Columbia University at the New York State Psychiatric Institute New York New York United States 10032
    4 Duke University Medical Center Durham North Carolina United States 27705
    5 University of Pittsburgh - Western Psychiatric Institute and Clinic Pittsburgh Pennsylvania United States 15213
    6 University of Texas, Southwestern Medical Center Dallas Texas United States 75235

    Sponsors and Collaborators

    • New York State Psychiatric Institute
    • National Institute of Mental Health (NIMH)

    Investigators

    • Study Chair: Laurence Greenhill, MD,

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    New York State Psychiatric Institute
    ClinicalTrials.gov Identifier:
    NCT00080158
    Other Study ID Numbers:
    • #4623
    • U10MH066762
    • U10MH066775
    • U10MH066778
    • U10MH066769
    • U10MH066750
    • DDTR B4-ARD
    • NCT00183534
    First Posted:
    Mar 26, 2004
    Last Update Posted:
    Jun 22, 2020
    Last Verified:
    Jun 1, 2020
    Keywords provided by New York State Psychiatric Institute
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jun 22, 2020